Jones Timothy L. 4
4 · RespireRx Pharmaceuticals Inc. · Filed Aug 4, 2020
Insider Transaction Report
Form 4
Jones Timothy L.
DirectorCEO and President
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2020-07-31+17,000,000→ 17,000,000 totalExercise: $0.01Exp: 2025-07-31→ Common Stock (17,000,000 underlying)
Footnotes (1)
- [F1]1,000,000 of these Common Stock Options were granted to Mr. Jones pursuant to his employment agreement, and vested upon issuance. The remaining 16,000,000 of these Common Stock Options were granted separately, and vest in four equal installments: 25 percent on July 31, 2020 (the grant date), 25 percent on September 30, 2020, 25 percent on December 31, 2020, and 25 percent on March 31, 2021.